Company intelligence / Profile preview

Solaris Biotech

Porto Mantovano, Mantova, Italy

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Solaris Biotech manufactures and supplies bioprocessing equipment (bioreactors, fermenters, TFF systems, CIP/SIP systems) spanning from laboratory to production scale; its technologies support upstream and downstream bioprocesses in pharma, biotech, food, agriculture, and related life science markets. Acquired by Donaldson Company in 2021, its market presence is global with facilities in Italy, the USA, and Malaysia. No drug development pipeline; Solaris is a platform solution and equipment provider[1][7][14][5][10].

Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Solaris Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solaris Biotech.

Explore the full profile